SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
122Approved pharma? Yes. Approved therapeutics, no. Several are in vivo diagnostscaram(o)uche-2/13/2001
121Ok, Where do I send the check? Are all of those approved Pharma?Elmer-2/13/2001
120anti-CD3 (murine, OKT3) anti-myosin (myoScint) anti-PSMA (ProstaScint) anti-TAG-scaram(o)uche-2/12/2001
119Hi Richard, I was reading research reports this weekend (which is often harmful Elmer-2/12/2001
118Feb. 12 /PRNewswire/ -- Avanir Pharmaceuticals (AMEX: AVN - news) today announcenigel bates-2/12/2001
117MARTINSRIED, Germany and MUNICH, Germany, Feb. 8 /PRNewswire/ -- MorphoSys (Neuenigel bates-2/8/2001
116Yeah. I guess that the focus has rapidly and AGGRESSIVELY turned to minimizatiscaram(o)uche-2/7/2001
115<i>Abgenix and Celltech</i> According to today's FT, Celltech wnigel bates-2/7/2001
114Feb. 7, 2001-- Panacea Pharmaceuticals, Inc. announced today that it has signed nigel bates-2/7/2001
113Feb. 6 /PRNewswire/ -- Medarex, Inc. (Nasdaq: MEDX - news) announced today that nigel bates-2/6/2001
112....and they only paid $77m for ImmGenics. Not a bad deal. <g> nignigel bates-2/6/2001
111$17 million? $17 muh...... muh.............. Wow. Look at this deal! An opscaram(o)uche-2/5/2001
110an. 31 /PRNewswire/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG - news) and Anigel bates-1/31/2001
109Jan. 30 /PRNewswire/ -- Abgenix, Inc. (Nasdaq: ABGX - news) today reported finannigel bates-1/30/2001
108Fun factoid..... Lonza derived from Celltech. Celltech once had a vaunted celscaram(o)uche-1/29/2001
107Jan. 29 /PRNewswire/ -- Abgenix, Inc. (Nasdaq: ABGX - news) today announced thatnigel bates-1/29/2001
106New development in Phage. doubletwist.comkeokalani'nui-1/22/2001
105Jan. 22/PRNewswire/ -- XTL Biopharmaceuticals Ltd ("XTL") (LSE: XTL) anigel bates-1/22/2001
104MSDW Report: "Therapeutic Antibodies: A Primer" MSDW just published tJongmans-1/19/2001
103Jan. 15 /PRNewswire/ -- Cambridge Antibody Technology (LSE: CAT) has announced tnigel bates-1/15/2001
102Also parking... crucell.com We have two technology platforms: a human cell linenigel bates-1/15/2001
101Let me park this here before I lose it again: smartmoney.com Focuses on MEDX aPseudo Biologist-1/9/2001
100Ha, you beat me to it, Stefaan. I was too busy buying a few of them (MEDX) ... nigel bates-1/9/2001
99and dont forget thi one for MEDX Tuesday January 9, 07:20 AM Related Quotes Odalroi-1/9/2001
98And not to be outdone, ABGX announce two (extensions of deals)... Jan. 9 /PRNewnigel bates-1/9/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News